Returning in person for its 10th year anniversary, the IMPACCT: Real World Evidence Summit will deep dive into the use of RWE for regulatory submissions and improved clinical trial design to help you navigate the regulatory landscape. Following recent FDA and EMA guidelines, this comprehensive industry-led forum will address how drug developers can leverage RWE from beginning to end of study, […]

With the exciting proof-of-concept milestones from Phlow, commitments from global regulatory agencies, and breakthroughs from the likes of AbbVie, AstraZeneca, Merck and BMS, over the last 12 months flow chemistry continues to take off at an exponential rate, further evidenced by the significant investments from CDMOs such as Almac, Corden Pharma, Sterling and Cambrex. Showcasing […]

The Innate Killer Summit Europe gathers 80+ key European Gamma Delta T, NK, and Macrophage developers in October to chase the holy grail of efficacious, off-the-shelf, solid tumour immunotherapies through innate cell targeting and engineering. Seize your chance to network with innate immune trailblazers from the likes of Sanofi, Takeda, Gamida Cell, Glycostem and Bayer and gain a comprehensive overview of candidates to inform your strategic development and progress […]

“The Process is the Product” - Drive Process Excellence at the Only Summit Dedicated to Process Development for Cell Therapies As momentum continues to build for the cell therapy industry, process development looms as a huge potential bottleneck to overcome. The inaugural Process Development for Cell Therapies Summit will give you unprecedented access to an […]

The 3rd Annual Gene Therapy Immunogenicity Summit is industry’s definitive forum enabling you to better modulate, measure and predict the immune response to your gene therapy candidate. In the context of ever-increasing gene therapy clinical activity and uncertainty around challenges posed by immune responses to delivery, this summit will unite large pharma and innovative biotech’s […]

With over 100 early and managed access, compassionate use, and named patient programmes running across the continent, the Operationalise: Early Access Programmes Summit Europe has been carefully curated to help you address difficulties with supply, logistics and cost, challenges with navigating European regulations, and planning and running equitable, patient-first early access programmes. Download the full event guide to view […]

Commercialization looks set to propel TIL therapy into the spotlight for adoptive cell therapy, and the 4th TIL Therapies Summit arrives to finally reunite the community in-person this October in Boston, MA. From preclinical conversations to the latest developments in streamlined manufacturing this year’s meeting will be the most comprehensive guide for addressing the unique […]

SAE Media Group’s 2nd Annual Biosensors for Medical Wearables *In collaboration with Medical Design Briefs* 24th – 25th October 2022 | Boston, MA, USA Sponsored by: Raumedic http://www.biosensors-medical-wear.com/PJWL Advances in development and therapeutic applications of on-body sensors SAE Media Group is proud to present the Biosensors for Medical Wearables Conference, taking place on the 24th […]

As more and more companies gear up for clinical activity and near approval decisions, the need to have an in-depth understanding of the regulatory frameworks and how these feed into clinical development and manufacturing processes is as vital as ever. This year’s summit is dedicated to gaining European regulatory clarity to progress efficient and robust gene […]

Returning to Boston this October, the 7th Annual Computational Drug Development (CDD) for Biologics Summit will continue to build on the reputation of past meetings while diving into the latest innovations in the industry. This year’s summit will highlight methods and best-practices to extrapolating data & leveraging deep learning for novel, complex biologics pipeline progression.  Across 3 days, we will unite […]

The Protein Engineering Biocatalysis Congress is the unique meeting point of industry, academia and service providers which will enable protein engineering and biocatalysis enthusiasts to industrialize sustainable enzyme products and increase product efficiency globally. This event will highlight case studies on scaling up protein engineering technologies for commercial scale. It is your opportunity to analyze developments […]

The 6th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases returns to Boston this fall. Ensure you join this year’s 150+ expert community in-person to: Uncover recent studies evaluating critical inflammatory and auto-immune pathways Gain a deeper understanding of promising biologics targeting IL-13, IL-31, IL-33, versus IL-17 associated diseases Assess emerging efficacious targeted approaches […]

Returning to Boston for 2022, the 6th Microbiome Movement- Human Nutrition Summit is the only industry focused meeting dedicated to exploring the latest innovations, practical applications and clinical benefits of microbiome targeting food, beverages and supplements to pave the route to commercial success in the consumer health setting. Get up to speed on this dynamic industry with […]

Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF, NASH, CKD and more in one place at one time, so you can advance the progress of your antifibrotic therapies. From exploring cellular mechanisms to identify a common fibrotic pathway to bridging the translational gap […]

SAE Media Group’s Inaugural Conference… Medical Devices and IVD 2022 14 – 15 November 2022 London, UK www.medicaldevices-ivd.com/PJ Navigating The MDR and IVDR and Best Strategies for Compliance  SAE Media Group is proud to announce the launch of the Medical Devices and IVD Conference, taking place on 14 – 15 November 2022 in London, UK. […]

The 7th Annual Microbiome Connect: USA 2022 is dedicated to showcasing the leading drug development platforms applying microbes, microbe modulators and microbial-derived components to prevent or treat human diseases or make medical diagnosis. As the first FDA approved microbiome-targeted therapeutic emerges, drug developers will have the opportunity to benchmark their rational drug platforms, targeting validated […]

Recognize Disease Hallmarks Earlier for Improved Patient Outcomes Gain Clarity Across Next Generation Non-Invasive Testing Technologies Revolutionizing Cancer Monitoring, MRD & Earlier Detection to Support Novel Pre-Metastatic Drug Development with Maximized Access In the wake of new FDA guidance and exciting MRD partnership announcements between Grail & AstraZeneca, Amgen & Bristol Myers Squibb the liquid […]

The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4th Annual Gene Therapy Analytical Development as an analytical scientist has never […]

Developing New Outcome Measures, Functional Biomarkers & Clinical Research Regulatory Frameworks for Disease-Modifying Therapeutics Across Neurodevelopmental & Rare, Genetic CNS Disorders With more clinical data emerging, neurodevelopmental drug development is advancing from hypotheticals to real-life clinical results, outcomes, and functional biomarkers, catapulting this critical field forwards. Join 100+ peers this November at the 2nd Rare […]

The 4th Inflammasome Therapeutics Summit is the only industry-led forum uniting large pharma, biotechs, and academic KOLs, with the common goal of accelerating the practical translation and clinical development of inflammasome-targeted drugs, which are shaking up the immunology R&D landscape. As the space eagerly awaits data readouts from proof-of-concept trials, and with more companies than […]

The first wave of investment in NASH is dispersing in the wake of highly demanding biopsy endpoints, but opportunities to target obesity and metabolic syndrome are catalyzing increasing excitement. Pivotal readouts in GLP-1 receptor agonists and exciting progress in regenerative medicine and microRNAs are redefining the drug development landscape for metabolic disorders. With mounting competition […]

Recognized with a Nobel Prize in 2020, CRISPR has opened the floodgates for a new era of gene editing therapies, promising to transform genetic disease treatments. With a well-established early field of genomics research, drug developers and researchers have been busy establishing the next-generation CRISPR toolkit, including Cas nucleases, base and prime editing technologies, and […]

The time has come to remove the pharmaceutical industry’s reliance on archaic off-line testing and embrace the cost and speed-to-market savings of online control and real-time product quality. The PAT market is projected to reach USD 4.96 Billion by 2027, spurred on by the recent ICH Q14/ Q2 (R2) guidelines, there has never been a more […]

Delivering the Next Wave of Gene Therapies to the CNS With systemic toxicity challenges plaguing the AAV field, direct administration for CNS indications creates an ideal target for gene therapy. This is an exciting year for the neurological space with clinical data to show and new biotechs coming out of the woodwork to release the […]

Cell Therapy Analytical Development Summit US is back for its fourth year, taking place in Boston (December 5-7). Join 180+ colleagues from analytical development, process development, quality control and regulatory affairs, to standardize analytical testing and take advantage of unrivalled content across: 3-days 6 deep-dive workshops 2 tracks Seize an unmatched opportunity to delve into cell potency, safety, viability, […]

The 5th Commercializing Clinically Validated Digital Therapeutics Summit, designed with DTx companies, pharma and clinicians, will return this December to address the industry’s major challenges such as improving user experience, clinical trial development, and standing out in a crowded market through open discussion and case-study led presentations.   Whether you’re a veteran at commercializing clinically […]

The long-awaited 4th Annual Targeted Radiopharmaceuticals Summit Europe is returning in-person in Amsterdam on December 6-8, 2022! As the only devoted meeting for large pharma, biotech and pioneering academics, this meeting unites key stakeholders under the mutual and ambitious objective of advancing radioligand candidates to commercialisation through rigorous clinical rationale and reliable supply chain design. Download the full Event Guide to learn what the 29+ expert speakers will […]

The field of food allergy therapeutics is continuing to boom as companies flood the news with fresh IND clearances and clinical readouts. The race to market for the next food allergy therapy is well and truly on, but access to funding and large patient cohorts, along with the need for novel IgE biomarkers and better […]

In the context of a need to regroup and accelerate practice-changing cancer immunotherapies towards approval and to patients in need, the 3rd TIGIT Axis Therapies Summit returns to reunite large pharma, innovative biotechs and pioneering academics to discuss the full range of next-generation TIGIT axis targeted drug modalities and maximize TIGIT-axis targeting in the solid tumor, blood cancer […]

RNA-Targeted Drug Discovery Summit returns for its fifth year this December. Join the summit for deep dive into new and emerging topics such as: Induced Proximity as a new class of "targeted RNA degraders” Next-generation probing and screening technologies to accelerate HIT identification and validation Biophysical, biochemical, and cell-based assay development strategies to identify and […]